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We retrospective1y ana1yzed the results of 104 patients who underwent a second prostate need1e 
biopsy. Between J anuary 1993 and September 2000， 654 need1e biopsies were performed and cancer 
was found in 239 patients. Among the other 415 patients， 104 patients underwent a second biopsy. 
The average prostate specific antigen (PSA) va1ue was 9.6 ng/m1 (2.0-30.9) (Tandem R conversion 
va1ue). Cancer was detected in 16 out of 104 cases (15%) at the second biopsy， 4 out of 39 (10%) at 
the third biopsy， and 3 out of 10 (30%) at the fourth biopsy. The age， PSA va1ue， digita1 examination， 
echography， and magnetic resonance imaging (MRI) were not helpful in distinguishing the patients 
with prostate cancer and atypica1 histological findings at the previous biopsy were the most important 
information. Among the 9 patients who showed atypica1 findings at the previous biopsy， 6(67%) had 
cancer. 
(Acta Uro1. Jpn. 48: 589-592， 2002) 

























生検の方法は 18Gの automaticspring loaded 
needleを使い，経直腸エコーガイド下に6箇所生検
を施行した.











(10%)， 4回目の生検では10人中 3人 (30%) に癌が
検出された.また病理組織にて atypicalsmall acinar 
proliferationまたは highgrade intraepithelial neo-
plasiaによって atypicalfindingsと診断された例は























Fig. 1. Biopsy of the prostate. 
Table 1. The comparison of age， PSA， PSAD 
and PSA V at the repeated biopsy 
(n) A(nVgE/rma号i:!:SD (ng/ml) P value 
Age Cancer (23) 70.8 6.2 コo凶
Benign (81) 68.2 7.7 
PSA Cancer (23) 9.3 5.0 コ0.763
Ber珂n(81) 9.7 5.3 
PSAD Cancer (13) 0.30 0.21 コ0.260
Benign (44) 0.24 0.12 
PSAV Cancer (12) 0.62 0.66 コ0.333





(P=0.260) (Table 1). 
5.再生検時の PSAvelocityの比較
再生検にて癌が検出された群とされなかった群のう











Table 2. Sensitivity and specificity on MRI， 
Echo and DRE* 
MRI Positi同 Negative 
Cancer 15 4 
Benign 45 32 
Total 60 36 
P=O.l18， Sensitivity=79%， Specificity=42 % . 
Echo Positive Negative 
Cancer 17 6 
Benign 42 39 
Total 59 45 
P=O.l34， Sensitivity=74%， Specificity=48 % . 
DRE* Positive Negative 
Cancer 15 8 
Benign 33 48 
Tota1 48 56 
P=0.027， Sensitivity=65% ， Specificity=59 % . 



































Wel1 dif. adenoca. highly suspect 
Wel1 dif. adenoca. highly suspect 
Adenoca. highly suspect 
























+ : positive findings (MRI: T2WI low intensity area. Echo: low-echoic area. DRE: palpable hard nodule.). 



















surface coilではなく骨盤用 phasedarray coilを使用
しており撮影法による違いの可能性も考えられた.












































Reported cases of repeated biopsy 
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